{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:58:30Z","timestamp":1781632710207,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsmedizin Rostock"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-026-03241-3","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T01:32:17Z","timestamp":1769995937000},"page":"850-863","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The coagulation\u2013inflammation axis in advanced cancer: associations with cardiovascular-thrombotic complications"],"prefix":"10.1007","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8269-1057","authenticated-orcid":false,"given":"Charlotte","family":"Wagner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Bruns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Maletzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabell","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moosheer","family":"Alammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anett","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Kriesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Rischm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Oehmcke-Hecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Junghanss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"3241_CR1","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","volume":"5","author":"AA Khorana","year":"2007","unstructured":"Khorana AA, Francis CW, Culakova E et al (2007) Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost 5:632\u2013634. https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02374.x","journal-title":"J Thromb Haemost"},{"key":"3241_CR2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jaccao.2021.03.001","volume":"3","author":"L Gervaso","year":"2021","unstructured":"Gervaso L, Dave H, Khorana AA (2021) Venous and Arterial Thromboembolism in Patients With Cancer: JACC: CardioOncology State-of-the-Art Review. JACC CardioOncol 3:173\u2013190. https:\/\/doi.org\/10.1016\/j.jaccao.2021.03.001","journal-title":"JACC CardioOncol"},{"key":"3241_CR3","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1001\/jama.293.6.715","volume":"293","author":"JW Blom","year":"2005","unstructured":"Blom JW, Doggen CJM, Osanto S et al (2005) Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 293:715\u2013722. https:\/\/doi.org\/10.1001\/jama.293.6.715","journal-title":"JAMA"},{"key":"3241_CR4","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1001\/archinte.160.6.809","volume":"160","author":"JA Heit","year":"2000","unstructured":"Heit JA, Silverstein MD, Mohr DN et al (2000) Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 160:809\u2013815. https:\/\/doi.org\/10.1001\/archinte.160.6.809","journal-title":"Arch Intern Med"},{"key":"3241_CR5","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.ejca.2012.10.021","volume":"49","author":"AJ Walker","year":"2013","unstructured":"Walker AJ, Card TR, West J et al (2013) Incidence of venous thromboembolism in patients with cancer - a cohort study using linked United Kingdom databases. Eur J Cancer 49:1404\u20131413. https:\/\/doi.org\/10.1016\/j.ejca.2012.10.021","journal-title":"Eur J Cancer"},{"key":"3241_CR6","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","volume":"111","author":"AA Khorana","year":"2008","unstructured":"Khorana AA, Kuderer NM, Culakova E et al (2008) Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111:4902\u20134907. https:\/\/doi.org\/10.1182\/blood-2007-10-116327","journal-title":"Blood"},{"key":"3241_CR7","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1182\/asheducation.V2014.1.410.3884864","volume":"2014","author":"I Pabinger","year":"2014","unstructured":"Pabinger I, Posch F (2014) Flamethrowers: blood cells and cancer thrombosis risk. Hematology 2014:410\u2013417. https:\/\/doi.org\/10.1182\/asheducation.V2014.1.410.3884864","journal-title":"Hematology"},{"key":"3241_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073447","volume":"8","author":"K Blix","year":"2013","unstructured":"Blix K, Jensvoll H, Br\u00e6kkan SK et al (2013) White blood cell count measured prior to cancer development is associated with future risk of venous thromboembolism\u2013the Troms\u00f8 study. PLoS ONE 8:e73447. https:\/\/doi.org\/10.1371\/journal.pone.0073447","journal-title":"PLoS ONE"},{"key":"3241_CR9","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann V, Reichard U, Goosmann C et al (2004) Neutrophil extracellular traps kill bacteria. Science 303:1532\u20131535. https:\/\/doi.org\/10.1126\/science.1092385","journal-title":"Science"},{"key":"3241_CR10","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1053\/j.seminoncol.2014.04.009","volume":"41","author":"GC Connolly","year":"2014","unstructured":"Connolly GC, Phipps RP, Francis CW (2014) Platelets and cancer-associated thrombosis. Semin Oncol 41:302\u2013310. https:\/\/doi.org\/10.1053\/j.seminoncol.2014.04.009","journal-title":"Semin Oncol"},{"key":"3241_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.7861\/clinmedicine.19-4-315","volume":"19","author":"S Noble","year":"2019","unstructured":"Noble S (2019) Venous thromboembolism and palliative care. Clin Med (Lond) 19:315\u2013318. https:\/\/doi.org\/10.7861\/clinmedicine.19-4-315","journal-title":"Clin Med (Lond)"},{"key":"3241_CR12","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1016\/S2352-3026(18)30215-1","volume":"6","author":"C White","year":"2019","unstructured":"White C, Noble SIR, Watson M et al (2019) Prevalence, symptom burden, and natural history of deep vein thrombosis in people with advanced cancer in specialist palliative care units (HIDDen): a prospective longitudinal observational study. Lancet Haematol 6:e79\u2013e88. https:\/\/doi.org\/10.1016\/S2352-3026(18)30215-1","journal-title":"Lancet Haematol"},{"key":"3241_CR13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/1049909107310142","volume":"25","author":"KA Kierner","year":"2008","unstructured":"Kierner KA, Gartner V, Schwarz M et al (2008) Use of thromboprophylaxis in palliative care patients: a survey among experts in palliative care, oncology, intensive care, and anticoagulation. Am J Hosp Palliat Care 25:127\u2013131. https:\/\/doi.org\/10.1177\/1049909107310142","journal-title":"Am J Hosp Palliat Care"},{"key":"3241_CR14","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.jtha.2023.02.029","volume":"21","author":"A Falanga","year":"2023","unstructured":"Falanga A, Marchetti M (2023) Cancer-associated thrombosis: enhanced awareness and pathophysiologic complexity. J Thromb Haemost 21:1397\u20131408. https:\/\/doi.org\/10.1016\/j.jtha.2023.02.029","journal-title":"J Thromb Haemost"},{"key":"3241_CR15","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s12185-024-03735-x","volume":"119","author":"K Tatsumi","year":"2024","unstructured":"Tatsumi K (2024) The pathogenesis of cancer-associated thrombosis. Int J Hematol 119:495\u2013504. https:\/\/doi.org\/10.1007\/s12185-024-03735-x","journal-title":"Int J Hematol"},{"key":"3241_CR16","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1111\/j.1538-7836.2012.04754.x","volume":"10","author":"J Thaler","year":"2012","unstructured":"Thaler J, Ay C, Mackman N et al (2012) Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients. J Thromb Haemost 10:1363\u20131370. https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04754.x","journal-title":"J Thromb Haemost"},{"key":"3241_CR17","doi-asserted-by":"publisher","first-page":"11553","DOI":"10.1007\/s13277-016-5098-7","volume":"37","author":"N Kumari","year":"2016","unstructured":"Kumari N, Dwarakanath BS, Das A et al (2016) Role of interleukin-6 in cancer progression and therapeutic resistance. Tumour Biol 37:11553\u201311572. https:\/\/doi.org\/10.1007\/s13277-016-5098-7","journal-title":"Tumour Biol"},{"key":"3241_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh JA, Goberdhan DCI, O\u2019Driscoll L et al (2024) Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles 13:e12404. https:\/\/doi.org\/10.1002\/jev2.12404","journal-title":"J Extracell Vesicles"},{"key":"3241_CR19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ijcard.2020.04.080","volume":"317","author":"J-C Youn","year":"2020","unstructured":"Youn J-C, Chung W-B, Ezekowitz JA et al (2020) Cardiovascular disease burden in adult patients with cancer: an 11-year nationwide population-based cohort study. Int J Cardiol 317:167\u2013173. https:\/\/doi.org\/10.1016\/j.ijcard.2020.04.080","journal-title":"Int J Cardiol"},{"key":"3241_CR20","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1136\/heartjnl-2022-321324","volume":"109","author":"Z Raisi-Estabragh","year":"2023","unstructured":"Raisi-Estabragh Z, Manisty CH, Cheng RK et al (2023) Burden and prognostic impact of cardiovascular disease in patients with cancer. Heart 109:1819\u20131826. https:\/\/doi.org\/10.1136\/heartjnl-2022-321324","journal-title":"Heart"},{"key":"3241_CR21","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1093\/eurheartj\/ehz766","volume":"40","author":"KM Sturgeon","year":"2019","unstructured":"Sturgeon KM, Deng L, Bluethmann SM et al (2019) A population-based study of cardiovascular disease mortality risk in US cancer patients. Eur Heart J 40:3889\u20133897. https:\/\/doi.org\/10.1093\/eurheartj\/ehz766","journal-title":"Eur Heart J"},{"key":"3241_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.acvd.2023.11.007","volume":"117","author":"G Pernod","year":"2024","unstructured":"Pernod G, Cohen A, Mismetti P et al (2024) Cancer-related arterial thromboembolic events. Arch Cardiovasc Dis 117:101\u2013113. https:\/\/doi.org\/10.1016\/j.acvd.2023.11.007","journal-title":"Arch Cardiovasc Dis"},{"key":"3241_CR23","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1538-7836.2006.01804.x","volume":"4","author":"JW Blom","year":"2006","unstructured":"Blom JW, Vanderschoot JPM, Oostindi\u00ebr MJ et al (2006) Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost 4:529\u2013535. https:\/\/doi.org\/10.1111\/j.1538-7836.2006.01804.x","journal-title":"J Thromb Haemost"},{"key":"3241_CR24","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1182\/blood.2020007338","volume":"137","author":"FI Mulder","year":"2021","unstructured":"Mulder FI, Horv\u00e1th-Puh\u00f3 E, van Es N et al (2021) Venous thromboembolism in cancer patients: a population-based cohort study. Blood 137:1959\u20131969. https:\/\/doi.org\/10.1182\/blood.2020007338","journal-title":"Blood"},{"key":"3241_CR25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jpainsymman.2013.08.016","volume":"48","author":"MJ Johnson","year":"2014","unstructured":"Johnson MJ, McMillan B, Fairhurst C et al (2014) Primary thromboprophylaxis in hospices: the association between risk of venous thromboembolism and development of symptoms. J Pain Symptom Manage 48:56\u201364. https:\/\/doi.org\/10.1016\/j.jpainsymman.2013.08.016","journal-title":"J Pain Symptom Manage"},{"key":"3241_CR26","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1056\/NEJMoa025313","volume":"349","author":"AYY Lee","year":"2003","unstructured":"Lee AYY, Levine MN, Baker RI et al (2003) Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 349:146\u2013153. https:\/\/doi.org\/10.1056\/NEJMoa025313","journal-title":"N Engl J Med"},{"key":"3241_CR27","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00520-007-0339-3","volume":"16","author":"C Weber","year":"2008","unstructured":"Weber C, Merminod T, Herrmann FR et al (2008) Prophylactic anti-coagulation in cancer palliative care: a prospective randomised study. Support Care Cancer 16:847\u2013852. https:\/\/doi.org\/10.1007\/s00520-007-0339-3","journal-title":"Support Care Cancer"},{"key":"3241_CR28","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/jth.13606","volume":"15","author":"B Tardy","year":"2017","unstructured":"Tardy B, Picard S, Guirimand F et al (2017) Bleeding risk of terminally ill patients hospitalized in palliative care units: the RHESO study. J Thromb Haemost 15:420\u2013428. https:\/\/doi.org\/10.1111\/jth.13606","journal-title":"J Thromb Haemost"},{"key":"3241_CR29","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1136\/pgmj.2007.061622","volume":"83","author":"S Noble","year":"2007","unstructured":"Noble S (2007) The challenges of managing cancer related venous thromboembolism in the palliative care setting. Postgrad Med J 83:671\u2013674. https:\/\/doi.org\/10.1136\/pgmj.2007.061622","journal-title":"Postgrad Med J"},{"key":"3241_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.853941","volume":"9","author":"J Li","year":"2022","unstructured":"Li J, Yan S, Zhang X et al (2022) Circulating D-dimers increase the risk of mortality and venous thromboembolism in patients with lung cancer: a systematic analysis combined with external validation. Front Med (Lausanne) 9:853941. https:\/\/doi.org\/10.3389\/fmed.2022.853941","journal-title":"Front Med (Lausanne)"},{"key":"3241_CR31","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1016\/j.ejso.2018.07.052","volume":"44","author":"Y Lin","year":"2018","unstructured":"Lin Y, Liu Z, Qiu Y et al (2018) Clinical significance of plasma D-dimer and fibrinogen in digestive cancer: a systematic review and meta-analysis. Eur J Surg Oncol 44:1494\u20131503. https:\/\/doi.org\/10.1016\/j.ejso.2018.07.052","journal-title":"Eur J Surg Oncol"},{"key":"3241_CR32","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/S0002-9343(99)00066-2","volume":"106","author":"TB Harris","year":"1999","unstructured":"Harris TB, Ferrucci L, Tracy RP et al (1999) Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 106:506\u2013512. https:\/\/doi.org\/10.1016\/S0002-9343(99)00066-2","journal-title":"Am J Med"},{"key":"3241_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25021082","author":"H Zhang","year":"2024","unstructured":"Zhang H, Dhalla NS (2024) The role of pro-inflammatory cytokines in the pathogenesis of cardiovascular disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25021082","journal-title":"Int J Mol Sci"},{"key":"3241_CR34","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.thromres.2013.06.026","volume":"132","author":"A Bharthuar","year":"2013","unstructured":"Bharthuar A, Khorana AA, Hutson A et al (2013) Circulating microparticle tissue factor, thromboembolism and survival in pancreaticobiliary cancers. Thromb Res 132:180\u2013184. https:\/\/doi.org\/10.1016\/j.thromres.2013.06.026","journal-title":"Thromb Res"},{"key":"3241_CR35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/jth.13181","volume":"14","author":"JE Geddings","year":"2016","unstructured":"Geddings JE, Hisada Y, Boulaftali Y et al (2016) Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice. J Thromb Haemost 14:153\u2013166. https:\/\/doi.org\/10.1111\/jth.13181","journal-title":"J Thromb Haemost"},{"key":"3241_CR36","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1182\/blood-2013-04-460139","volume":"122","author":"JE Geddings","year":"2013","unstructured":"Geddings JE, Mackman N (2013) Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients. Blood 122:1873\u20131880. https:\/\/doi.org\/10.1182\/blood-2013-04-460139","journal-title":"Blood"},{"key":"3241_CR37","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1111\/j.1538-7836.2008.02987.x","volume":"6","author":"M Davila","year":"2008","unstructured":"Davila M, Amirkhosravi A, Coll E et al (2008) Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation. J Thromb Haemost 6:1517\u20131524. https:\/\/doi.org\/10.1111\/j.1538-7836.2008.02987.x","journal-title":"J Thromb Haemost"},{"key":"3241_CR38","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.thromres.2011.06.004","volume":"129","author":"RD Lee","year":"2012","unstructured":"Lee RD, Barcel DA, Williams JC et al (2012) Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity. Thromb Res 129:80\u201385. https:\/\/doi.org\/10.1016\/j.thromres.2011.06.004","journal-title":"Thromb Res"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03241-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-026-03241-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03241-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:30:01Z","timestamp":1781631001000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-026-03241-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["3241"],"URL":"https:\/\/doi.org\/10.1007\/s11239-026-03241-3","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"9 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"The ethics committee of the Rostock University Medical Center, University of Rostock (Ethikkommission an der Medizinischen Fakult\u00e4t der Universit\u00e4t Rostock, St.-Georg-Str. 108, 18055 Rostock, Germany; reference number A 2024-0068) reviewed and approved the study, and all procedures adhered to the principles outlined in the Declaration of Helsinki. Inclusion was based on written informed consent and additional verbal counseling, irrespective of prior therapies or pre-existing conditions.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}